These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8868343)

  • 1. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy for cystic fibrosis by means of aerosol.
    Rochat T; Morris MA
    J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for cystic fibrosis: which postman, which box?
    Middleton PG; Alton EW
    Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic therapy in mucoviscidosis].
    Bellon G; Pavirani A
    Arch Pediatr; 2000 May; 7 Suppl 2():355s-357s. PubMed ID: 10904772
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspectives on gene therapy for cystic fibrosis airway disease.
    Bigger B; Coutelle C
    BioDrugs; 2001; 15(9):615-34. PubMed ID: 11580305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy for CF.
    Eubanks M
    Environ Health Perspect; 2001 Jan; 109(1):A16. PubMed ID: 11171534
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is gene therapy in cystic fibrosis a realistic expectation?
    McElvaney NG
    Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and future prospects for the treatment of lung disease in cystic fibrosis by gene therapy.
    Porteous DJ
    Pulm Pharmacol; 1994 Jun; 7(3):153-7. PubMed ID: 7530071
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on gene therapy for cystic fibrosis.
    Griesenbach U; Geddes DM; Alton EW
    Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward cystic fibrosis gene therapy.
    Wagner JA; Gardner P
    Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene transfer to gene therapy in cystic fibrosis, how long is the road?].
    Bellon G
    Rev Prat; 1998 Jan; 48(1):5-8. PubMed ID: 9781203
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy in cystic fibrosis: from lab benches to lungs.
    Arthur G
    Lancet Respir Med; 2015 Jul; 3(7):521-2. PubMed ID: 26070912
    [No Abstract]   [Full Text] [Related]  

  • 18. Delivery of genes into the CF airway.
    Gill DR; Hyde SC
    Thorax; 2014 Oct; 69(10):962-4. PubMed ID: 25015239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer for cystic fibrosis.
    Welsh MJ
    J Clin Invest; 1999 Nov; 104(9):1165-6. PubMed ID: 10545512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.